About Apellis Pharma (APLS)
Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. The Company's lead compounds are designed to inhibit ... Read more
- USD36.24
- USD37.84
- USD36.10
- USD73.80
- -4.30%
- 629M
- 919.30k
- 1.16M
- 4.6B
- 33.49
- -24.20%
Stock News
1 hour ago
Insurance giant CEO shares the No. 1 piece of career advice that helped her get ahead—it's 'especially' important right now
CNBC
1 hour ago
Bond spreads for ‘Magnificent Seven’ tighten as investors celebrate interest-rate cut
MarketWatch
1 hour ago
Don't let Abbott Labs' litigation overhang keep you out of the stock
CNBC
1 hour ago
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
